Tested Applications
| Positive WB detected in | HeLa cells, HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
25649-1-AP targets TNFAIP2 in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, canine |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag19150 Product name: Recombinant human TNFAIP2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 88-431 aa of BC128449 Sequence: RQIRLLEATFLSSEAANVRELMDRALELEARRWAEDVPPQRLDGHCHSELAIDIIQITSQAQAKAESITLDLGSQIKRVLLVELPAFLRSYQRAFNEFLERGKQLTNYRANVIANINNCLSFRMSMEQNWQVPQDTLSLLLGPLGELKSHGFDTLLQNLHEDLKPLFKRFTHTRWAAPVETLENIIATVDTRLPEFSELQGCFREELMEALHLHLVKEYIIQLSKGRLVLKTAEQQQQLAGYILANADTIQHFCTQHGSPATWLQPALPTLAEIIRLQDPSAIKIEVATYATCYPDFSKGHLSAILAIKGNLSNSEVKRIRSILDVSMGAQEPSRPLFSLIKVG Predict reactive species |
| Full Name | tumor necrosis factor, alpha-induced protein 2 |
| Calculated Molecular Weight | 654 aa, 73 kDa |
| Observed Molecular Weight | 73 kDa |
| GenBank Accession Number | BC128449 |
| Gene Symbol | TNFAIP2 |
| Gene ID (NCBI) | 7127 |
| RRID | AB_2918092 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q03169 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TNFAIP2, also named as B94, belongs to the SEC6 family. TNFAIP2 may play a role as a mediator of inflammation and angiogenesis. TNFAIP2 is differentially expressed in development and capillary tube-like formation in vitro. It is induced by TNFα and other proinflammatory factors.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for TNFAIP2 antibody 25649-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TNFAIP2 Polyclonal antibody (Cat# 25649-1-AP) has 6 total citations published in Pharmacol Res, Cell Commun Signal, Cell Rep, Exp Cell Res, BMC Pharmacol Toxicol, and Biologicals. Research fields span stem cell therapy and implantation, esophageal carcinoma, adipose inflammation and insulin resistance, nasopharyngeal carcinoma with EMT, bladder cancer progression, and tumorigenesis inhibition.
| Species | Application | Title |
|---|---|---|
Pharmacol Res Targeted MSC therapy restores implantation by spatially reconstituting the RSPO1 niche via IL10-CXCL12 signaling. | ||
Cell Commun Signal NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression | ||
Cell Rep Tunneling nanotube-mediated stem cell immunomodulation dysfunction promotes adipose inflammation and insulin resistance in GDM. | ||
Exp Cell Res TGF-β-Induced Acetylation of KLF5 Drives TNFAIP2 Transcription and EMT in Nasopharyngeal Carcinoma: Unveiling a Novel Regulatory Mechanism | ||
BMC Pharmacol Toxicol Imidacloprid contributes to bladder cancer progression: preliminary evidence based on network toxicology, machine learning and molecular docking. | ||
